To our knowledge, the current study demonstrated for the first time that miR-223 directly inhibits HSC activation and proliferation by targeting Gli2 and Pdgfra/b, thus ameliorating liver fibrosis. The gene discussed is GLI2; the disease is Hepatic fibrosis.